The tumor microenvironment strongly polarizes macrophage differentiation while generating tumor-associated macrophages (TAM), and B7-H4+ macrophages can suppress specific T cell immune responses (Kryczek et al., 2006). The gene discussed is VTCN1; the disease is neoplasm.